“No matter how much technology we bring into the system, healthcare is a human enterprise.” — Adam Resnick, PhD, Co-Executive Director of the Center for Data-Driven Discovery in Biomedicine (D3b) at Children’s Hospital of Philadelphia
For too long, medicine has happened to patients. Families have contributed data, enrolled in studies, and endured treatments, yet discoveries often remain locked away in research for years before ever reaching the bedside. Decisions were made without their input, and many felt excluded from the conversation about their own care.
RADIANT—Real-time Analysis and Discovery in Integrated and Networked Technologies—changes that. It brings families into the process as active partners. By merging medical records, genetic information, and scans simultaneously, RADIANT empowers patients and clinicians alike to see more options, act with greater precision, and share in shaping the future of care.
It’s a new way forward: data democratized, privacy safeguarded, and decision-making shared.
Why the Patient Voice Matters
Children’s Brain Tumor Network (CBTN) was modeled with the belief that data, when shared, can accelerate cures. But sharing data is only part of the equation. The other is recognizing patients and families as essential voices in that process.
“RADIANT is going to bridge that gap between research and clinical care by bringing in multiomic data, imaging data, and clinical data into a common environment,” explains Resnick. “Through AI-empowered tools, we can deliver real-time personalized information back to the clinician and the patient.”
